Back to Search
Start Over
Effect of methylprednisolone on acute kidney injury in patients undergoing cardiac surgery with a cardiopulmonary bypass pump: a randomized controlled trial
- Source :
- CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 191(9)
- Publication Year :
- 2019
-
Abstract
- BACKGROUND: Perioperative corticosteroid use may reduce acute kidney injury. We sought to test whether methylprednisolone reduces the risk of acute kidney injury after cardiac surgery. METHODS: We conducted a prespecified substudy of a randomized controlled trial involving patients undergoing cardiac surgery with cardiopulmonary bypass (2007-2014); patients were recruited from 79 centres in 18 countries. Eligibility criteria included a moderate-to-high risk of perioperative death based on a preoperative score of 6 or greater on the European System for Cardiac Operative Risk Evaluation I. Patients (n = 7286) were randomly assigned (1:1) to receive intravenous methylprednisolone (250 mg at anesthetic induction and 250 mg at initiation of cardiopulmonary bypass) or placebo. Patients, caregivers, data collectors and outcome adjudicators were unaware of the assigned intervention. The primary outcome was postoperative acute kidney injury, defined as an increase in the serum creatinine concentration (from the preoperative value) of 0.3 mg/dL or greater (≥ 26.5 μmol/L) or 50% or greater in the 14-day period after surgery, or use of dialysis within 30 days after surgery. RESULTS: Acute kidney injury occurred in 1479/3647 patients (40.6%) in the methylprednisolone group and in 1426/3639 patients (39.2%) in the placebo group (adjusted relative risk 1.04, 95% confidence interval 0.96 to 1.11). Results were consistent across several definitions of acute kidney injury and in patients with preoperative chronic kidney disease. INTERPRETATION: Intraoperative corticosteroid use did not reduce the risk of acute kidney injury in patients with a moderate-to-high risk of perioperative death who had cardiac surgery with cardiopulmonary bypass. Our results do not support the prophylactic use of steroids during cardiopulmonary bypass surgery. Trial registration: ClinicalTrials.gov, no. NCT00427388. ispartof: CANADIAN MEDICAL ASSOCIATION JOURNAL vol:191 issue:9 pages:E247-E256 ispartof: location:Canada status: published
- Subjects :
- Male
medicine.medical_specialty
medicine.medical_treatment
Anti-Inflammatory Agents
030204 cardiovascular system & hematology
Methylprednisolone
Drug Administration Schedule
law.invention
03 medical and health sciences
Medicine, General & Internal
0302 clinical medicine
Postoperative Complications
Randomized controlled trial
law
General & Internal Medicine
Cardiopulmonary bypass
SIRS
Medicine
Humans
030212 general & internal medicine
Cardiac Surgical Procedures
Glucocorticoids
Dialysis
Aged
Science & Technology
Cardiopulmonary Bypass
business.industry
STEROIDS
Research
Acute kidney injury
General Medicine
Perioperative
Acute Kidney Injury
Middle Aged
medicine.disease
Cardiac surgery
HIGH-DOSE DEXAMETHASONE
Anesthesia
Female
business
Life Sciences & Biomedicine
Kidney disease
medicine.drug
Subjects
Details
- ISSN :
- 14882329
- Volume :
- 191
- Issue :
- 9
- Database :
- OpenAIRE
- Journal :
- CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
- Accession number :
- edsair.doi.dedup.....bd6affa0ee430f4bf9a0f480284120c5